Powered exoskeleton

ReWalk Robotics to Report Third Quarter 2020 Financial Results on November 10, 2020

Retrieved on: 
Friday, November 6, 2020

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.

2020 Market Study on Opportunities of Robotics in the Enterprise Industry - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 21, 2020

The "Opportunities of Robotics in Enterprise Industry" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Opportunities of Robotics in Enterprise Industry" report has been added to ResearchAndMarkets.com's offering.
  • With the advent of Industry 4.0 and smart factories, all industries across the spectrum are adopting advanced robotic automation solutions for varied applications according to industry requirements.
  • The Growth Opportunity report on Opportunities of Robotics in Enterprise Industry discusses the impact of Collaborative Robots, Material Handling Robots and Robotic Exoskeletons in the Enterprise Industry.
  • 7.1 Growth Opportunity 1: R&D Investment for Technological Innovation, 2020 - Cobots
    7.2 Growth Opportunity 2: R&D Investment for Technological Innovation, 2020 - Material Handling & Warehouse Robot
    7.3 Growth Opportunity 3: R&D Investment for Technological Innovation, 2020 - Robotic Exoskeleton

ReWalk Robotics announces the Appointment of Randel E. Richner, BSN, MPH to its Board of Directors

Retrieved on: 
Monday, October 19, 2020

and YOKNEAM ILIT, Israel and BERLIN, Oct. 19, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics.

Key Points: 
  • and YOKNEAM ILIT, Israel and BERLIN, Oct. 19, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics.
  • Ltd. (NASDAQ: RWLK) (ReWalk or the Company) announced today that the Company has approved the appointment of Randel Richner to the Board of Directors, effective November 1, 2020.
  • Jeff Dykan, Chairman of ReWalk Robotics states, As ReWalk advances its commercialization pathway, Randel has an ideal combination of operating industry knowledge and reimbursement policy establishment.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Global Medical Exoskeletons Market | Use of Medical Exoskeletons During Rehabilitation to Boost the Market Growth | Technavio

Retrieved on: 
Monday, October 12, 2020

Therefore, such advantages of medical exoskeletons during rehabilitation will significantly influence medical exoskeleton market growth over the forecast period.

Key Points: 
  • Therefore, such advantages of medical exoskeletons during rehabilitation will significantly influence medical exoskeleton market growth over the forecast period.
  • North America was the largest market for medical exoskeletons in 2019, and the region will offer several growth opportunities to market vendors during the forecast period.
  • To help clients improve their market position, these medical exoskeletons market forecast report provides a detailed analysis of the market leaders.
  • As the business impact of COVID-19 spreads, the global medical exoskeletons market 2020-2024 is expected to have Positive and Superior growth.

ReWalk Robotics to Present at the H.C. WAINWRIGHT 22nd Annual Global Investment Virtual Conference on September 15th, 2020

Retrieved on: 
Thursday, September 10, 2020

and BERLIN and YOKNEAM ILIT, Israel, Sept. 10, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (ReWalk or the Company) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon, Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement, will present at the H.C. WAINWRIGHT virtual conference at 11:00 EST on Tuesday, September 15, 2020.

Key Points: 
  • and BERLIN and YOKNEAM ILIT, Israel, Sept. 10, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (ReWalk or the Company) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon, Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement, will present at the H.C. WAINWRIGHT virtual conference at 11:00 EST on Tuesday, September 15, 2020.
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalkis a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.

Retired Lt. General Anthony Ierardi Joins Sarcos Robotics Strategic Advisory Board

Retrieved on: 
Wednesday, September 9, 2020

Sarcos Robotics , a global leader in the production of robots that augment humans to enhance productivity and safety, including full-body, powered exoskeletons for industrial and military applications, and its wholly-owned subsidiary, Sarcos Defense , today announced the appointment of Lieutenant General Anthony Tony Ierardi (Ret.)

Key Points: 
  • Sarcos Robotics , a global leader in the production of robots that augment humans to enhance productivity and safety, including full-body, powered exoskeletons for industrial and military applications, and its wholly-owned subsidiary, Sarcos Defense , today announced the appointment of Lieutenant General Anthony Tony Ierardi (Ret.)
  • to the Sarcos Strategic Advisory Board.
  • View the full release here: https://www.businesswire.com/news/home/20200909005383/en/
    Retired Lt. General Anthony Ierardi Joins Sarcos Robotics Strategic Advisory Board (Photo: Business Wire)
    Lt. Gen. Ierardi served in the U.S. military for more than 37 years.
  • I am delighted to welcome Tony to our advisory board, said Ben Wolff, chairman and chief executive officer, Sarcos Robotics.

ReWalk Robotics Reports Second Quarter 2020 Financial Results

Retrieved on: 
Wednesday, August 12, 2020

ReWalk Robotics Ltd. develops, manufactures, and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures, and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.
  • ReStore is a registered trademark of ReWalk Robotics Ltd. in Europe and an allowed trademark in the United States.
  • ReWalk urges investors to review the reconciliation of the Companys non-GAAP financial measures to the comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate the Companys business.

ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020

Retrieved on: 
Friday, August 7, 2020

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.

Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics’ Exoskeleton Device for Rehabilitation Following Successful Trial

Retrieved on: 
Thursday, July 9, 2020

As part of its comprehensive fall prevention program, ADF has invested in and implemented new technology and innovation like the EksoGT exoskeleton device.

Key Points: 
  • As part of its comprehensive fall prevention program, ADF has invested in and implemented new technology and innovation like the EksoGT exoskeleton device.
  • Through the program, ADF began trialing the use of EksoGT for rehabilitation with older adults at Knollwood in February 2018.
  • Thirty people completed the EksoGT therapy, which has improved gait, balance, strength and mobility, contributing to fewer falls, according to ADF.
  • The adoption of the EksoGT robotic exoskeleton was a natural choice for providing technology-enhanced health care in our community.

Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients

Retrieved on: 
Thursday, June 25, 2020

EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use with ABI, significantly expanding the devices indication to a broader group of patients.

Key Points: 
  • EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use with ABI, significantly expanding the devices indication to a broader group of patients.
  • EksoNR is the next generation device of the most clinically used robotic exoskeleton, and was previously cleared by the FDA for stroke and spinal cord injury rehabilitation in 2016.
  • ABI is the broadest category of brain injury and is comprised of both traumatic (TBI) and non-traumatic (n-TBI) causes.
  • EksoNR is cleared by the FDA for stroke, spinal cord injury, and acquired brain injury rehabilitation.